Background illustration for clinical trials search

Paid Clinical Trials Wisconsin

Discover 1,093 paid clinical trials in Wisconsin. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Worcester MA, Hartford CT, New Haven CT, New York NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase3, Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07008118

Phase1, Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase3, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Chicoutimi, New York NY, Summit NJ, New Brunswick NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase2, Phase3, Recruiting

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Tampa FL, Madison WI
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06940440

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Acute Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: Kallyope Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase3, Recruiting

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

for
Heart Failure
Location: New York NY, Washington D.C. DC, Richmond VA,
Sponsor: VA Office of Research and Development

Sex: All

Age: 60+

Code: NCT05996328

Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Boston MA, The Bronx NY, New York NY, East Brunswick NJ,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase3, Recruiting

A Study Of Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals

for
Burnout, Healthcare Workers, Breathing Exercises
Location: Eau Claire WI
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT07218458

Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Boston MA, New York NY, Hackensack NJ, Baltimore MD,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase2, Recruiting

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Charlotte NC,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT07116616

Phase1, Phase2, Recruiting

Ivosidenib as Post-HSCT Maintenance for AML

for
IDH1 Mutation, Acute Myeloid Leukemia (AML),
Location: Boston MA, Columbus OH, Atlanta GA, Milwaukee WI,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT06707493

Phase2, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Bath ME, Portland ME, Scarborough ME, Sanford ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase3, Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Scarborough ME, New York NY, East Brunswick NJ,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase2, Recruiting

Calls and Coordination for Transitions of Care at Re-entry

for
Prisoners, Substance Use History, Chronic Medical Conditions,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT06794983

Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase3, Recruiting

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

for
Aortic Dissection
Location: Boston MA, Westchester NY, Hackensack NJ,
Sponsor: W.L.Gore & Associates

Sex: All

Age: 18+

Code: NCT06827990

Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Long Island City NY, Danbury CT, Great Neck NY,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

for
Metastatic Castration-resistant Prostate Cancer,
Location: New Hyde Park NY, New York NY, Myrtle Beach SC,
Sponsor: K36 Therapeutics, Inc.

Sex: Male

Age: 18+

Code: NCT07103018

Phase1, Recruiting

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Waterford CT,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase2, Recruiting

Popular cities in Wisconsin

The state of Wisconsin offers a substantial healthcare network and renowned medical research institutions, making it a prime location for clinical research into a variety of conditions. Leading centers such as the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and Froedtert Hospital are state leaders in medical research. These institutions, known for their innovative approaches, provide a strong foundation for conducting clinical trials that advance medical knowledge and treatment options.

Why choose Wisconsin for clinical trials?

There are several reasons why researchers conduct clinical trials in Wisconsin. Firstly, the state’s diverse population provides a wide range of participants, which enhances the accuracy and applicability of research outcomes. Wisconsin is also home to a thriving research community, with a strong emphasis on medical innovation and innovative studies that push boundaries.

By choosing to participate in a clinical trial in Wisconsin, you play a crucial role in advancing medical research while benefiting from a well-established and supportive clinical research environment, backed by renowned institutions and expert healthcare professionals.

Common conditions studied in Wisconsin

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Wisconsin